Watson Rebecca’s GSK GSK Stock Holding History

Watson Rebecca’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-382	Closed	-$19K	–	195
2020 Q2	$19K	Buy	+382	New	+$19.6K	0.01%	225

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Watson Rebecca's GSK Position: Q3 2020 in Review

Watson Rebecca sold out of GSK (GSK) in Q3 2020, closing a stake of 382 shares — an estimated $19K sold.

Watson Rebecca first reported a position in GSK in Q2 2020 and held it in 1 quarter. The position peaked at $19K in Q2 2020. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Watson Rebecca reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 382 GSK shares in Q3 2020, an estimated $19K.
Watson Rebecca first reported a position in GSK in Q2 2020 and held it in 1 quarter.
Watson Rebecca's GSK position peaked at $19K in Q2 2020.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.